New research indicates that people who come off new slimming jabs like Mounjaro or Wegovy tend to recover lost weight far faster than those who stop conventional lifestyle programs.
Findings released in a leading health publication demonstrates that while overweight individuals can lose a large proportion of their total mass while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"People buying these treatments need to be informed of the potential of fast weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.
This pace of recovery implies a reversion to pre-treatment mass in about one and a half years.
Analyzing Treatments
The research, which reviewed 37 of studies involving thousands of patients, contrasted the results of these new drugs with conventional dieting.
Scientists emphasize that individuals who lose weight through diet and exercise usually have a less rapid creep back—approximately 100 grams monthly—after stopping.
Understanding the Quick Rebound
Experts suggest the mechanism of the drugs accounts for the accelerated rebound.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication leads to appetite is no longer kept in check, making excessive eating a significant risk."
A Chronic Issue?
The NHS suggest the injections for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Professionals say that, given the high risk of weight regain, the therapy might need to be life-long.
This perspective is supported by pharmaceutical companies, who state that the findings "emphasize the persistent nature of obesity," akin to managing conditions like hypertension.
Patient Testimonies
People who have stopped the medication explain a intense resurgence of cravings.
"It was like a switch activating and you become starving," recalled a patient.
This difficulty is compounded if users have not established permanent dietary or behavioural changes during treatment.
Significant Adoption
Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is higher among women than males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
In conclusion, clinicians emphasize that while these medications are effective tools for weight loss, they are not a magic fix and long-term success likely depends on combined behavioural changes.
